Bristol-Myers Squibb Company(BMY)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
BMY | 125.99 B | 12.72x | 5.70% | 18.87% | $4.85 | 46.60% | 2.02x | 4.14% | $68.64 | $42.52 |
LLY | 1.14 T | 41.58x | 47.70% | 33.53% | $30.87 | 102.29% | 1.62x | 0.52% | $1292.65 | $778.94 |
JNJ | 625.03 B | 29.44x | 5.90% | 16.20% | $8.81 | - | 0.58x | 0.51% | $281.07 | $180.59 |
MRK | 365.88 B | 117.70x | 5.10% | 4.77% | $1.26 | 6.96% | 1.28x | 2.29% | $156.00 | $79.67 |
PFE | 171.62 B | 38.11x | 2.60% | 6.80% | $0.79 | 5.01% | 0.74x | 5.84% | $29.88 | $22.57 |
Peer Valuation & Performance Analysis
Peer group analysis for Bristol-Myers Squibb Company (BMY) compared to its primary competitors (including LLY, JNJ, MRK) reveals distinct metrics. BMY trades at a valuation discount relative to its competitors, with a P/E ratio of 12.7x versus the peer average of 56.7x (representing a 78% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, BMY's revenue growth of 5.7% lags behind the peer average of 15.3%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 18.9% compared to the peer average of 15.3%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• BMY ranks #1 in P/E ratio, #3 in revenue growth, and #2 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $59.93 | $61.81 | $59.84 | $61.68 | 11,902,919 | +4.84% |
| 2026-10-19 | $59.40 | $59.87 | $58.44 | $58.83 | 11,549,700 | -1.54% |
| 2026-10-16 | $61.10 | $61.43 | $59.54 | $59.75 | 13,770,800 | -1.35% |
| 2026-10-15 | $60.67 | $62.25 | $60.39 | $60.57 | 13,752,200 | +2.18% |
| 2026-10-14 | $56.81 | $59.39 | $56.58 | $59.28 | 14,045,600 | +4.61% |
| 2026-10-13 | $57.78 | $58.02 | $56.15 | $56.67 | 16,958,100 | -1.58% |
| 2026-10-12 | $60.11 | $60.68 | $56.72 | $57.58 | 22,564,700 | -2.60% |
| 2026-10-09 | $58.88 | $59.79 | $58.74 | $59.12 | 9,252,700 | -0.77% |
| 2026-10-08 | $59.10 | $59.94 | $58.73 | $59.58 | 13,070,600 | -0.20% |
| 2026-10-07 | $59.45 | $60.10 | $59.01 | $59.70 | 11,091,200 | +0.18% |
| 2026-10-06 | $58.94 | $59.60 | $58.64 | $59.59 | 9,885,400 | +1.33% |
| 2026-10-05 | $59.89 | $60.15 | $58.33 | $58.81 | 19,237,900 | -3.83% |
| 2026-10-02 | $60.66 | $61.24 | $60.24 | $61.15 | 9,933,500 | +0.53% |
| 2026-10-01 | $61.56 | $61.97 | $60.62 | $60.83 | 10,768,200 | -1.51% |
| 2026-09-30 | $62.63 | $63.47 | $61.76 | $61.76 | 15,867,300 | -0.73% |
Explore More Analysis for BMY
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.